Chordoma Global Clinical Trials Review 2012

Chordoma Global Clinical Trials Review, H1, 2012 Published: February 2012

No. of Pages: 52

Price: US$1000

GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H1, 2012" provides data on the Chordoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chordoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chordoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis

by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope   

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy    

Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Chordoma Clinical Trials Table of Contents  

Table of Contents 2 List of Tables 3 List of Figures 3 Introduction 4 Chordoma 4 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Five Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Top Countries Contributing to Clinical Trials in Central and South America 11



 

Clinical Trials by G7 Nations 12 Clinical Trials in G7 Nations by Trial Status 13 Clinical Trials by Phase 14 In Progress Trials by Phase 15 Clinical Trials by Trial Status 16 Unaccomplished Trials of Chordoma 17 Subjects Recruited Over a Period of Time 18 Prominent Sponsors 19 Prominent Drug Comparison 21 Clinical Trial Profiles 22 Clinical Trial Overview of Top Companies 22 Novartis AG 22 Clinical Trial Overview of Novartis AG 22 Clinical Trial Overview of Top Universities / Institutes / Hospitals 23 Massachusetts General Hospital 23 Clinical Trial Overview of Massachusetts General Hospital 23 Sarcoma Alliance for Research through Collaboration 24 Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 24 St. John's Mercy Health Care 25 Clinical Trial Overview of St. John's Mercy Health Care 25 University of Virginia 26 Clinical Trial Overview of University of Virginia 26 The University of Texas M. D. Anderson Cancer Center 27 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 27 Five Key Clinical Profiles 28 Appendix 49 Abbreviations 49 Definitions 49 Research Methodology 50 Secondary Research 50 About GlobalData 51 Contact Us 51 Disclaimer 51 Source 52 List of Tables Chordoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 5 Chordoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 6 Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 7 Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 8 Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 9 Chordoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 10 Chordoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 11 Chordoma Therapeutics Clinical Trials, G7 Countries, 2012* 12 Chordoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13 Chordoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 14 Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 15 Chordoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16 Chordoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 17 Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 18 Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20 Chordoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21 Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 22 Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 23 Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2012* 24

 

Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Mercy Health Care, 2012* 25 Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2012* 26 Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 27 List of Figures Chordoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 5 Chordoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 6 Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 7 Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 8 Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 9 Chordoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 10 Chordoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 11 Chordoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 12 Chordoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13 Chordoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 14 Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 15 Chordoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16 Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 18 Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 19 Chordoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21 GlobalData Methodology 50